Keywords: oncological diseases, anemia, metabolic disorders, serotonin, histamine, heparin, blood plasma


Colorectal cancer is one of the most common oncological diseases, therefore, the study of this problem is an important issue in clinical practice. This problem becomes especially urgent in case of the formation of anemic syndrome in patients, which causes the emergence of a mutual burden syndrome and increases the risks for a patient. The progressive nature of anemia in colorectal cancer is accompanied by secondary metabolic disorders. The material for the study was the blood plasma of 445 patients (228 men and 217 women). Among them, 53 patients (31 women and 22 men) with iron deficiency anemia were examined and included in the first observation group (І) and 392 patients (206 men (52,55 %) and 186 women (47.45 %)) with colorectal cancer whose course of the underlying disease was burdened with anemia in neoplastic disease were included in the second observation group (II). Among the patients in the second (II) observation group, there were 222 individuals (119 men and 103 women) with malignant neoplasms of the colon (ICD-10 code: С.18), 29 individuals (16 men and 13 women) with malignant neoplasms of the rectosigmoid junction (ICD-10 code: C.19), 138 individuals (82 men and 56 women) with malignant neoplasms of the rectum (code ICD-10 C.20) and 3 patients (2 men and 1 woman) with malignant neoplasms of the anus (ICD-10 code: C.21). The age of the examined patients was from 22 to 79 years. It was found that prior to the initiation of treatment in patients with anemia in neoplastic disease, regardless of the course of colorectal cancer, there was a significant increase in the plasma level of free fractions of heparin, histamine and serotonin (p < 0,001); the ratio of histamine: serotonin was also changed in comparison with the values in the control group (p < 0,05), which indicated both an increased release of heparin, histamine and serotonin from the depot, and an impaired inactivation processes of these biologically active substances. It was correctly concluded that in addition to the baseline therapy the administration of arginine glutamate which causes both antihypoxic and membrane-stabilizing action, reliably contributes to the normalization of secondary metabolic disorders of histamine, serotonin and heparin metabolism in anemia in neoplastic disease in patients with colorectal cancer.


Avni, T., Bieber, A., Grossman, A. (2015) The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc., 90(1), 12-23. doi: 10/1016/j.mayocp.2014.10.007
Berganaschi, G., Di Sabatino, A., Pasini, A. (2017) Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin. Clinical Nutrition, 36, 1427-1433. doi: 10/S0261-5614((16)31261-4
Borysenko, D, Vydyborets, S. (2020) Soderzhanie glukozy v erytrozytah pazientov s anemiej zlokachestvennogo novoobrazovaniya pri urotelialnom rake mochevogo puzyria [The contents of glucose in erythrocytes of patients with anemia of malignant neoplasm in urothelial cancer of the urinary bladder]. Hematologija. Transfusiologija. Vostochnaya Evropa,. 6(3), 319-323. doi: 10.34883/PI2020.6.3.17. [in Russian]
Gordienko, AV, Sakhin, VT, Kryukov, EV, Sotnikov, AV, Rukavitsyn, OA (2018) Znachenie obmena zheleza, gepcidina i rastvorimogo receptora transferrina v patogeneze anemii u pacientov, stradayushchih zlokachestvennymi novoobrazovaniyami [Significance of the exchange of iron, hepcidin, and soluble transferring receptor in the pathogenesis of anemia in patients with malignant neoplasms]. Bulletin of the Russian Military Medical Academy, 63(3), 91-94. [in Russian]
Mykhailychenko, BV, Vydyborets, SV. (2000) Metod kil’kisnogo vyznatshennia geparynu v biosubstratah [Method of quantative determination of heparin in biological speciments]. Laboratorna diagnostika, 4: 53-56. [in Ukrainian]
Mykhailichenko, BV, Vydyborets, SV. (1999) Metod odnochasnogo fluorymetrychnogo vyznachennja biogennych aminiv v analizovanij probi biosubstratu [The metod of simultaneousfluorimetric assay of biogenic amines in biological speciments]. Laboratorna diagnostika, 2: 58-61. [in Ukrainian]
Okam, MM, Koch, TA, Than M-H. (2017) Iron supplementation, response in iron deficiency anemia: analysis of five trials. Am. J. Med., 130(8), 991.e1-991.e8. doi:10/1016/amjmed.2017.03.045
Tymchenko, A, Zalessky V. (2019) Reguliatornoe vlijanie vospaleniya na kostno-mozgovoe krovotvorenie: gerontologicheskie i onkologicheskie aspekty [Regulatory Impact of Inflammation on Hematopoiesis in Bone Marrow: Aging and Cancer Aspects]. Laboratornaja diagnostika. Vostochnaya Evropa. 8 (2), 237-248. [in Russian]
Vydyborets, SV, Andriiaka, AO. (2017) Fiziologichna rol gepsidinu jak zentralnogo regulyatora meabolizmu zaliza (oglyad literatury) [The physiological role of hepcidin as a central regulator of iron metabolism (literature review). Simejna medyzyna. Family medicine, 1(69), 154-157. [in Ukrainian]
Weiss, G, Ganz, T, Goodnungh, LT. (2019) Iron metabolism and its disorders. Anemia of inflammation. Blood, 133(1), 40-50. doi:10.1182/blood-201806-856500
Zhang, J. (2020) Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: A systematic review and meta-analysis based on 15 randomized controlled trails. Postgraduate Medical Journal, 96(1142), 1664-1672. doi: 10.1136/postgradmedj-2019-137342.

Abstract views: 124
PDF Downloads: 77
How to Cite
Andriiaka, A., & Vydyborets, S. (2022). OPTIMIZATION OF DIAGNOSIS OF SECONDARY METABOLIC DISORDERS AND TREATMENT TACTICS IN PATIENTS WITH ANEMIA IN NEOPLASTIC DISEASE IN COLORECTAL CANCER. Scientific Journal of Polonia University, 48(5), 132-141. https://doi.org/10.23856/4817